Correlation Between Wuhan General and CbdMD
Can any of the company-specific risk be diversified away by investing in both Wuhan General and CbdMD at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Wuhan General and CbdMD into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Wuhan General Gr and cbdMD Inc, you can compare the effects of market volatilities on Wuhan General and CbdMD and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Wuhan General with a short position of CbdMD. Check out your portfolio center. Please also check ongoing floating volatility patterns of Wuhan General and CbdMD.
Diversification Opportunities for Wuhan General and CbdMD
0.0 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Wuhan and CbdMD is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Wuhan General Gr and cbdMD Inc in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on cbdMD Inc and Wuhan General is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Wuhan General Gr are associated (or correlated) with CbdMD. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of cbdMD Inc has no effect on the direction of Wuhan General i.e., Wuhan General and CbdMD go up and down completely randomly.
Pair Corralation between Wuhan General and CbdMD
If you would invest 80.00 in cbdMD Inc on November 29, 2024 and sell it today you would earn a total of 64.00 from holding cbdMD Inc or generate 80.0% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Flat |
Strength | Insignificant |
Accuracy | 0.0% |
Values | Daily Returns |
Wuhan General Gr vs. cbdMD Inc
Performance |
Timeline |
Wuhan General Gr |
Risk-Adjusted Performance
Very Weak
Weak | Strong |
cbdMD Inc |
Wuhan General and CbdMD Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Wuhan General and CbdMD
The main advantage of trading using opposite Wuhan General and CbdMD positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Wuhan General position performs unexpectedly, CbdMD can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in CbdMD will offset losses from the drop in CbdMD's long position.Wuhan General vs. Biome Grow | Wuhan General vs. Halo Collective | Wuhan General vs. Cannara Biotech | Wuhan General vs. Avicanna |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Forecasting module to use basic forecasting models to generate price predictions and determine price momentum.
Other Complementary Tools
Share Portfolio Track or share privately all of your investments from the convenience of any device | |
Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance |